PALI (Palisade Bio) FCF Margin %: 0.00% (As of Mar. 2026)


PALI Palisade Bio Inc PALI
35 GF Score
Price $1.90
! 2 Warning Signs
View Full Analysis

What is Palisade Bio FCF Margin %?

Palisade Bio PALI +5.59% 35 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates PALI with a GF Score™ of 35/100. The stock has 2 warning signs investors should review. Among 959 Biotechnology companies, Palisade Bio ranks worse than 104275.18% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Palisade Bio's Free Cash Flow for the three months ended in Mar. 2026 was $-3.89 Mil. Palisade Bio's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Palisade Bio's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Palisade Bio's current FCF Yield % is -3.78%.

The historical rank and industry rank for Palisade Bio's FCF Margin % or its related term are showing as below:


During the past 6 years, the highest FCF Margin % of Palisade Bio was -4454.80%. The lowest was -4454.80%. And the median was -4454.80%.

PALI's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -84.65
* Ranked among companies with meaningful FCF Margin % only.

Palisade Bio FCF Margin % Related Terms

Palisade Bio FCF Margin % Historical Data

* Premium members only.

The historical data trend for Palisade Bio's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Palisade Bio FCF Margin % Chart

Palisade Bio Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial 0.00 0.00 -4,454.80 0.00 0.00

Palisade Bio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PALI vs PBYI, NWBO, PROK: FCF Margin % Comparison

For the Biotechnology subindustry, Palisade Bio's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Palisade Bio FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Palisade Bio's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Palisade Bio's FCF Margin % falls into.


PALI
35GF Score
Palisade Bio Inc PALI
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Palisade Bio FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Palisade Bio's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-10.847/0
= %

Palisade Bio's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-3.89/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Palisade Bio (PALI) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Palisade Bio and its competitors. According to the industry distribution chart, Palisade Bio ranks #999999 out of 959 companies in the Biotechnology industry.
Is Palisade Bio's FCF Margin % too high?
Palisade Bio's current FCF Margin % is 0.00%. Based on the distribution chart, Palisade Bio ranks #999999 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Palisade Bio has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Palisade Bio's FCF Margin % compare to PBYI and NWBO?
According to the Biotechnology industry distribution chart, Palisade Bio ranks #999999 out of 959 companies for FCF Margin %. This places Palisade Bio in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Palisade Bio and its competitors. Palisade Bio's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Palisade Bio stock overvalued right now?
Palisade Bio (PALI) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Palisade Bio's overall GF Score™ is 35/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Palisade Bio (PALI), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Palisade Bio Business Description

Address 4600 South Syracuse Street, Suite 900, Denver, CO, USA, 80237
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
35GF Score

Get the complete analysis for PALI

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.90
Price